CIK: 0001281446 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $522,016 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| URGN | UROGEN PHARMA LTD | 2,906,259 | $48,767 | 9.3% | $15.87 | -10.4% | COM | M96088105 |
| NGNE | NEUROGENE INC | 1,004,291 | $36,546 | 7.0% | $14.51 | +143.1% | COM | 64135M105 |
| ABVX | ABIVAX SA | 2,472,188 | $32,682 | 6.3% | $12.06 | — | SPONSORED ADS | 00370M103 |
| — | MERUS N V | 523,288 | $30,963 | 5.9% | $52.47 | — | COM | N5749R100 |
| PLRX | PLIANT THERAPEUTICS INC | 2,636,864 | $28,346 | 5.4% | $16.18 | -20.3% | COM | 729139105 |
| ACLX | ARCELLX INC | 492,000 | $27,153 | 5.2% | $56.99 | -4.6% | COMMON STOCK | 03940C100 |
| — | DYNAVAX TECHNOLOGIES CORP | 2,374,000 | $26,660 | 5.1% | $11.86 | — | COM NEW | 268158201 |
| EOLS | EVOLUS INC | 2,451,772 | $26,602 | 5.1% | $9.65 | +27.4% | COM | 30052C107 |
| CYTK | CYTOKINETICS INC | 474,202 | $25,692 | 4.9% | $51.75 | +16.6% | COM NEW | 23282W605 |
| DNTH | DIANTHUS THERAPEUTICS INC | 757,929 | $19,615 | 3.8% | $22.14 | +8.6% | COM | 252828108 |
| INSM | INSMED INC | 250,000 | $16,750 | 3.2% | $26.50 | +46.4% | COM PAR $.01 | 457669307 |
| ZURA | ZURA BIO LTD | 4,642,241 | $16,248 | 3.1% | $6.43 | -36.6% | CLASS A ORD SHS | G9TY5A101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,338,568 | $15,768 | 3.0% | $11.67 | 0.0% | COM | 483497103 |
| IONS | IONIS PHARMACEUTICALS INC | 330,000 | $15,728 | 3.0% | $41.01 | 0.0% | COM | 462222100 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $14,876 | 2.8% | $1.72 | 0.0% | COM | 21077P108 |
| FOLD | AMICUS THERAPEUTICS INC | 1,495,500 | $14,835 | 2.8% | $12.08 | -15.0% | COM | 03152W109 |
| — | OPTINOSE INC | 13,727,097 | $14,276 | 2.7% | $1.52 | — | COM | 68404V100 |
| ESPR | ESPERION THERAPEUTICS INC NE | 5,791,594 | $12,857 | 2.5% | $2.43 | -3.2% | COM | 29664W105 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,601,527 | $12,668 | 2.4% | $7.91 | — | COM | 92915B106 |
| OTLK | OUTLOOK THERAPEUTICS INC | 1,701,510 | $12,557 | 2.4% | $8.08 | -0.6% | COM | 69012T305 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 3,441,667 | $11,977 | 2.3% | $4.46 | — | SPON ADS | 05280R100 |
| JSPR | JASPER THERAPEUTICS INC | 402,015 | $9,126 | 1.7% | $17.76 | +35.0% | COM NEW | 471871202 |
| OLMA | OLEMA PHARMACEUTICALS INC | 796,880 | $8,622 | 1.7% | $10.84 | 0.0% | COM | 68062P106 |
| TERN | TERNS PHARMACEUTICALS INC | 1,149,406 | $7,827 | 1.5% | $5.81 | +4.3% | COM | 880881107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 500,000 | $6,505 | 1.2% | $19.39 | -28.6% | COM | 92790C104 |
| TCRX | TSCAN THERAPEUTICS INC | 940,831 | $5,504 | 1.1% | $7.88 | 0.0% | COM | 89854M101 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,529,338 | $5,322 | 1.0% | $3.78 | +14.4% | COM | 92840H400 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5,110 | 1.0% | $10.35 | -0.6% | CL A ORD SHS | G4444H101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,486,544 | $4,846 | 0.9% | $3.77 | +16.6% | COM | 74587V107 |
| KYTX | KYVERNA THERAPEUTICS INC | 499,152 | $3,744 | 0.7% | $19.05 | -19.8% | COM | 501976104 |
| SYRE | SPYRE THERAPEUTICS INC | 134,612 | $3,165 | 0.6% | $15.20 | +121.9% | COM NEW | 00773J202 |
| ANAB | ANAPTYSBIO INC | 25,000 | $627 | 0.1% | $23.39 | -0.5% | COM | 032724106 |
| LXRX | LEXICON PHARMACEUTICALS INC | 30,000 | $50 | 0.0% | $1.79 | 0.0% | COM NEW | 528872302 |